CA
NZ
UK
AU
IND
US
…
QTREX Quantum Ltd., engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure and advanced connectivity solutions for the quantum computing industry in Israel and USA. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers HYLA blood sensor, which is designed to perform real-time sampling and analysis of key blood parameter measurements. In addition, The company offers cryogenic interconnects systems are generally built from multiple discrete components assembled and verified in a manual process. It also develops a monolithic interconnect architecture that integrates the conductor, radio-frequency dielectric, shielding, thermal management, and mechanical routing into a single engineered structure, designed to replace discrete, manually assembled cabling and support higher channel density and reliability. In addition, It offers AME Platform, provides the manufacturing foundation for our quantum connectivity development efforts and also operates as a commercial business serving customers across aerospace, missile, defense, and advanced electronics sectors. The company was formerly known as Inspira Technologies Oxy B.H.N. Ltd. and changed its name to QTREX Quantum Ltd. in May 2026. QTREX Quantum Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public filings and widely available information on QTREX Quantum Ltd. (NASDAQ: QTEX) are limited, so its business operations and financial profile are not well documented. The name suggests a focus on quantum technologies that could benefit from long-term demand for quantum computing, but investors should confirm strategy and commercialization plans in company filings.
Principal risks include limited public disclosure and unclear revenue or profitability, execution and commercialization risk for advanced technology, potential need for additional financing, and low trading liquidity.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
| Income before tax | -13.22M | -11.05M | -11.29M | -14.98M |
| Net income | -13.22M | -11.05M | -11.29M | -14.98M |
| Selling general administrative | 5.88M | 4.69M | 4.57M | 6.50M |
| Gross profit | 0.00M | 0.00M | 0.00M | - |
| Reconciled depreciation | 0.15M | 0.17M | 0.11M | 0.05M |
| Operating income | -13.62M | -11.27M | -12.13M | -14.89M |
| Interest expense | - | - | 0.00M | 0.04M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M |
| Interest income | 0.06M | 0.17M | 0.32M | 0.19M |
| Net interest income | 0.30M | 0.14M | 0.61M | 0.45M |
| Total revenue | 0.29M | 0.00M | 0.00M | 0.00M |
| Total operating expenses | 13.91M | 11.27M | 12.13M | 14.89M |
| Cost of revenue | 0.29M | 0.00M | 0.00M | - |
| Total other income expense net | 0.10M | 0.08M | 0.23M | -0.53M |
| Net income from continuing ops | -13.22M | -11.05M | -11.29M | -14.98M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
| Total assets | 5.34M | 8.07M | 9.31M | 16.17M |
| Other current assets | 0.20M | 0.26M | 0.17M | 0.28M |
| Total liab | 3.02M | 3.75M | 3.57M | 2.54M |
| Total stockholder equity | 2.32M | 4.32M | 5.74M | 13.63M |
| Other current liab | 1.08M | 1.57M | 1.47M | 0.03M |
| Capital stock | 82.12M | 70.90M | 61.26M | 57.87M |
| Retained earnings | -79.79M | -66.57M | -55.52M | -44.23M |
| Cash | 3.16M | 5.11M | 5.04M | 6.78M |
| Total current liabilities | 2.82M | 3.37M | 2.98M | 1.66M |
| Total current assets | 4.41M | 6.81M | 7.79M | 14.49M |
| Short term investments | 0.00M | 0.67M | 2.32M | - |
| Long term debt | - | - | - | 0.40M |
| Inventory | 0.73M | 0.44M | 0.00M | - |
| Accounts payable | 0.11M | 0.15M | 0.20M | 0.15M |
| Non current assets total | 0.93M | 1.26M | 1.52M | 1.67M |
| Capital lease obligations | 0.48M | 0.66M | 0.88M | 1.14M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
| Investments | - | - | 4.80M | -7.12M |
| Net borrowings | - | - | 0.00M | -0.40M |
| Total cash from financing activities | 7.33M | 7.90M | 3.45M | 0.00M |
| Net income | -13.22M | -11.05M | -11.29M | -10.27M |
| Change in cash | -1.97M | 0.02M | -1.64M | -16.59M |
| Begin period cash flow | 5.20M | 5.13M | 6.84M | 23.87M |
| End period cash flow | 3.26M | 5.20M | 5.13M | 6.84M |
| Total cash from operating activities | -9.86M | -9.37M | -9.69M | -9.21M |
| Issuance of capital stock | 6.41M | 7.90M | 3.45M | 0.00M |
| Depreciation | 0.15M | 0.17M | 0.11M | 0.05M |
| Change to inventory | -0.29M | -0.44M | 0.00M | 0.00M |
| Capital expenditures | 0.10M | 0.16M | 0.21M | 0.26M |
| Change in working capital | -0.22M | -0.42M | 0.04M | 0.56M |
| Stock based compensation | 3.58M | 1.89M | 1.49M | 4.88M |
| Other non cash items | 0.59M | 0.04M | 0.20M | -0.05M |
| Free cash flow | -9.96M | -9.54M | -9.90M | -9.47M |
Sector: Technology Industry: Computer Hardware
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| QTEX QTREX Quantum Ltd. |
0.10 11.04% |
1.03 | - | 8.25 | 196.26 | 24.59 | 188.43 | -0.15 |
| SNDK Sandisk Corp |
28.37 3.52% |
834.80 | 21.05 | 6.87 | 11.07 | 14.44 | 11.00 | 16.82 |
| STX Seagate Technology PLC |
-4.97 1.07% |
461.56 | 57.81 | 22.52 | 14.39 | 84.53 | 15.20 | 43.61 |
| DELL Dell Technologies Inc |
13.24 4.18% |
330.15 | 24.44 | 15.65 | 1.22 | 4.39 | 1.34 | 12.81 |
| ANET Arista Networks |
11.64 7.31% |
170.80 | 39.49 | 31.45 | 13.08 | 11.15 | 12.18 | 31.54 |
QTREX Quantum Ltd., engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure and advanced connectivity solutions for the quantum computing industry in Israel and USA. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers HYLA blood sensor, which is designed to perform real-time sampling and analysis of key blood parameter measurements. In addition, The company offers cryogenic interconnects systems are generally built from multiple discrete components assembled and verified in a manual process. It also develops a monolithic interconnect architecture that integrates the conductor, radio-frequency dielectric, shielding, thermal management, and mechanical routing into a single engineered structure, designed to replace discrete, manually assembled cabling and support higher channel density and reliability. In addition, It offers AME Platform, provides the manufacturing foundation for our quantum connectivity development efforts and also operates as a commercial business serving customers across aerospace, missile, defense, and advanced electronics sectors. The company was formerly known as Inspira Technologies Oxy B.H.N. Ltd. and changed its name to QTREX Quantum Ltd. in May 2026. QTREX Quantum Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
| Name | Title | Year Born |
|---|---|---|
| Mr. Dagi Shahar Ben-Noon | Co-Founder, CEO & Director | 1976 |
| Ms. Yafit Tehila | Chief Financial Officer | 1981 |
| Mr. Avi Shabtai | COO and VP of Research & Development | 1974 |
| Ms. Daniella Yeheskely-Hayon M.B.A., Ph.D. | Chief Technology Officer | 1976 |
| Ms. Sivan Ozeri | Administrative Manager | NA |
| Adi Shmueli | Director of Marketing | NA |
| Mr. Mike Hershkovitz | Vice President of Global Sales | NA |
| Mr. Yoav Rozanovich | Chief Business Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.61%
Communication Services
-0.21%
Consumer Cyclical
-0.26%
Consumer Defensive
-0.37%
Energy
+0.23%
Financial Services
-0.43%
Financials
+0.39%
Healthcare
+0.88%
Industrials
+0.36%
Real Estate
-0.51%
Technology
+1.35%
Utilities
+0.19%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...